Sintx Tech Gains Full Coronavirus Stock Status With New Study
Sintx Technologies shares nearly tripled after the company announced a big win against the coronavirus in a controlled laboratory study.
All Work
Chris Lange
Why This FDA Approval Puts Evoke Pharma in the Money
Evoke Pharma says the FDA has approved its New Drug Application for Gimoti nasal spray for symptom relief in adults with acute and recurrent diabetic gastroparesis.
Tyson Foods Is Playing a Game of COVID Chicken With China
Tyson Foods took a hit on Monday after it came to light that China’s customs agency has suspended poultry imports from one of the company’s facilities in Arkansas. The suspension is COVID-19 related.
What Virgin Galactic’s NASA Deal Means for Space Flight Privatization
Virgin Galactic has signed a Space Act Agreement with NASA’s Johnson Space Center to encourage commercial participation in orbital human spaceflight to the International Space Station.
BlackBerry, KB Home, Nike and More Earnings Coming This Week
Here, 24/7 Wall St. offers a preview of what to expect from BlackBerry, Nike and some of the other key companies on deck to report quarterly results this week.
Penn National Gaming Moves All In on Reopening Efforts
An update on its gaming and racing properties helped boost Penn National Gaming shares to close out the week.
DraftKings Ups the Ante in Secondary Offering
DraftKings is moving forward with its secondary offering, but it will be upsized from the previous announcement.
2020 IPO Next-Gen Cancer Screening AnPac Sees Growth in US and China
The announcement that AnPac Bio-Medical Science has entered into a three-year strategic cancer screening collaboration contract with Beijing Yuan Jian Health Management in China lit a fire under the shares Friday morning.
Are Smith & Wesson Earnings Really Not Enough for Investors?
Strong consumer demand for firearms helped Smith & Wesson deliver growth and market share gains in its firearms business in fiscal 2020.
Why Spotify’s DC Deal Is All Around Super
Spotify Technology is putting on its cape and saving the day for investors with its newest superhero deal with DC Comics.
How Sarepta and Selecta Bio Are Taking the Fight to DMD
Selecta Biosciences and Sarepta Therapeutics have announced that they had entered into a research license and option agreement.
Has Alpine Immune Sciences Found the Deal of a Lifetime?
Alpine Immune Sciences shares doubled on Thursday after the company announced a license agreement with AbbVie for its ALPN-101.
Kroger Earnings: When Good Isn’t Good Enough
Kroger reported better than expected fiscal first-quarter financial results before the markets opened on Thursday, but shares retreated on a lack of guidance.
Why This Analyst Sees Beyond Meat’s Prospects Improving
Beyond Meat has announced a new product line just in time for summer, and one key analyst has hiked his target price for the faux meat firm as well.
One Analyst Has Risked a Big Buy Rating on Nikola Stock
Nikola shares saw a handy gain on Wednesday after the first analyst got behind this electric vehicle manufacturer.
Aclaris Therapeutics Takes the Next Big Step Toward COVID Treatment
Aclaris Therapeutics has received an update from FDA regarding the use of its ATI-450 in hospitalized patients with COVID-19.
DraftKings Decides to Capitalize With Secondary Offering
Companies usually pursue secondary offerings as a way to raise capital after their stock has made a solid run. This is the case with DraftKings.
Is Groupon Back on Track After Q1?
Groupon reported first-quarter financial results after markets closed on Tuesday. The company said that it had a net loss of $1.63 per share and $374.2 million in revenue, beating analysts' consensus estimates on both…
Are Oracle Earnings Good Enough For Investors?
Oracle released fiscal fourth-quarter results after markets closed Tuesday. The firm reported $1.20 in earnings per share and $10.44 billion in revenue. Consensus estimates called for $1.16 in EPS and revenue of $10.67 billion.
How Weight Watchers’ Parent Just Became the Newest COVID-19 Stock
Weight Watchers is looking to deal with the excess weight that some people may have put on during the pandemic stay-at-home period.